nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—Protein urine present—Methotrexate—esophageal cancer	0.00194	0.00318	CcSEcCtD
Delavirdine—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00194	0.00317	CcSEcCtD
Delavirdine—Pancreatitis—Cisplatin—esophageal cancer	0.00194	0.00317	CcSEcCtD
Delavirdine—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00193	0.00315	CcSEcCtD
Delavirdine—Sweating increased—Cisplatin—esophageal cancer	0.00193	0.00315	CcSEcCtD
Delavirdine—Polyuria—Capecitabine—esophageal cancer	0.00192	0.00314	CcSEcCtD
Delavirdine—Bone disorder—Methotrexate—esophageal cancer	0.00191	0.00313	CcSEcCtD
Delavirdine—Swelling—Capecitabine—esophageal cancer	0.00191	0.00313	CcSEcCtD
Delavirdine—Gastroenteritis—Capecitabine—esophageal cancer	0.0019	0.00311	CcSEcCtD
Delavirdine—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.0019	0.00311	CcSEcCtD
Delavirdine—Vascular purpura—Capecitabine—esophageal cancer	0.00189	0.00308	CcSEcCtD
Delavirdine—Pancytopenia—Cisplatin—esophageal cancer	0.00188	0.00307	CcSEcCtD
Delavirdine—Glossitis—Methotrexate—esophageal cancer	0.00188	0.00307	CcSEcCtD
Delavirdine—Hepatic failure—Capecitabine—esophageal cancer	0.00188	0.00307	CcSEcCtD
Delavirdine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00187	0.00306	CcSEcCtD
Delavirdine—Hyperuricaemia—Methotrexate—esophageal cancer	0.00186	0.00305	CcSEcCtD
Delavirdine—Ulcer—Methotrexate—esophageal cancer	0.00183	0.00299	CcSEcCtD
Delavirdine—Renal failure acute—Capecitabine—esophageal cancer	0.00183	0.00299	CcSEcCtD
Delavirdine—Libido decreased—Capecitabine—esophageal cancer	0.00182	0.00298	CcSEcCtD
Delavirdine—Amnesia—Capecitabine—esophageal cancer	0.0018	0.00294	CcSEcCtD
Delavirdine—Increased appetite—Capecitabine—esophageal cancer	0.0018	0.00294	CcSEcCtD
Delavirdine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00179	0.00292	CcSEcCtD
Delavirdine—Inflammation—Methotrexate—esophageal cancer	0.00178	0.00292	CcSEcCtD
Delavirdine—Thirst—Capecitabine—esophageal cancer	0.00177	0.0029	CcSEcCtD
Delavirdine—Dermatitis bullous—Capecitabine—esophageal cancer	0.00176	0.00289	CcSEcCtD
Delavirdine—Blood uric acid increased—Methotrexate—esophageal cancer	0.00176	0.00288	CcSEcCtD
Delavirdine—Purpura—Capecitabine—esophageal cancer	0.00175	0.00286	CcSEcCtD
Delavirdine—Arthritis—Capecitabine—esophageal cancer	0.00174	0.00284	CcSEcCtD
Delavirdine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00173	0.00283	CcSEcCtD
Delavirdine—Cardiac failure—Capecitabine—esophageal cancer	0.00173	0.00283	CcSEcCtD
Delavirdine—Lethargy—Capecitabine—esophageal cancer	0.00172	0.00282	CcSEcCtD
Delavirdine—Stomatitis—Cisplatin—esophageal cancer	0.00172	0.00281	CcSEcCtD
Delavirdine—Conjunctivitis—Cisplatin—esophageal cancer	0.00171	0.0028	CcSEcCtD
Delavirdine—Hyponatraemia—Capecitabine—esophageal cancer	0.00169	0.00277	CcSEcCtD
Delavirdine—Diplopia—Capecitabine—esophageal cancer	0.00169	0.00276	CcSEcCtD
Delavirdine—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00169	0.00276	CcSEcCtD
Delavirdine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00167	0.00274	CcSEcCtD
Delavirdine—Migraine—Capecitabine—esophageal cancer	0.00166	0.00272	CcSEcCtD
Delavirdine—Skin exfoliation—Methotrexate—esophageal cancer	0.00165	0.0027	CcSEcCtD
Delavirdine—Bradycardia—Cisplatin—esophageal cancer	0.00161	0.00264	CcSEcCtD
Delavirdine—Mood swings—Capecitabine—esophageal cancer	0.0016	0.00261	CcSEcCtD
Delavirdine—Blood creatinine increased—Capecitabine—esophageal cancer	0.00158	0.00258	CcSEcCtD
Delavirdine—Urine output increased—Methotrexate—esophageal cancer	0.00156	0.00256	CcSEcCtD
Delavirdine—Ecchymosis—Methotrexate—esophageal cancer	0.00156	0.00256	CcSEcCtD
Delavirdine—Mouth ulceration—Methotrexate—esophageal cancer	0.00156	0.00256	CcSEcCtD
Delavirdine—Dry skin—Capecitabine—esophageal cancer	0.00155	0.00253	CcSEcCtD
Delavirdine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00154	0.00252	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00152	0.00248	CcSEcCtD
Delavirdine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00152	0.00248	CcSEcCtD
Delavirdine—Gastritis—Capecitabine—esophageal cancer	0.00149	0.00244	CcSEcCtD
Delavirdine—Muscular weakness—Capecitabine—esophageal cancer	0.00149	0.00243	CcSEcCtD
Delavirdine—Tinnitus—Cisplatin—esophageal cancer	0.00148	0.00241	CcSEcCtD
Delavirdine—Lymphadenopathy—Methotrexate—esophageal cancer	0.00147	0.00241	CcSEcCtD
Delavirdine—Abdominal distension—Capecitabine—esophageal cancer	0.00147	0.0024	CcSEcCtD
Delavirdine—Influenza—Capecitabine—esophageal cancer	0.00146	0.00238	CcSEcCtD
Delavirdine—Dysphagia—Capecitabine—esophageal cancer	0.00146	0.00238	CcSEcCtD
Delavirdine—Polyuria—Methotrexate—esophageal cancer	0.00143	0.00234	CcSEcCtD
Delavirdine—Sweating increased—Capecitabine—esophageal cancer	0.00142	0.00232	CcSEcCtD
Delavirdine—Bronchitis—Capecitabine—esophageal cancer	0.0014	0.00229	CcSEcCtD
Delavirdine—Alopecia—Cisplatin—esophageal cancer	0.0014	0.00229	CcSEcCtD
Delavirdine—Hepatic failure—Methotrexate—esophageal cancer	0.0014	0.00229	CcSEcCtD
Delavirdine—Pancytopenia—Capecitabine—esophageal cancer	0.00138	0.00226	CcSEcCtD
Delavirdine—Erythema—Cisplatin—esophageal cancer	0.00138	0.00225	CcSEcCtD
Delavirdine—Malnutrition—Cisplatin—esophageal cancer	0.00138	0.00225	CcSEcCtD
Delavirdine—Neutropenia—Capecitabine—esophageal cancer	0.00136	0.00223	CcSEcCtD
Delavirdine—Renal failure acute—Methotrexate—esophageal cancer	0.00136	0.00222	CcSEcCtD
Delavirdine—Flatulence—Cisplatin—esophageal cancer	0.00136	0.00222	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00135	0.00222	CcSEcCtD
Delavirdine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00133	0.00218	CcSEcCtD
Delavirdine—Weight increased—Capecitabine—esophageal cancer	0.00133	0.00217	CcSEcCtD
Delavirdine—Muscle spasms—Cisplatin—esophageal cancer	0.00132	0.00217	CcSEcCtD
Delavirdine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00131	0.00215	CcSEcCtD
Delavirdine—Pneumonia—Capecitabine—esophageal cancer	0.00131	0.00214	CcSEcCtD
Delavirdine—Vision blurred—Cisplatin—esophageal cancer	0.0013	0.00212	CcSEcCtD
Delavirdine—Tremor—Cisplatin—esophageal cancer	0.00129	0.00211	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00129	0.00211	CcSEcCtD
Delavirdine—Lethargy—Methotrexate—esophageal cancer	0.00128	0.0021	CcSEcCtD
Delavirdine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00128	0.00209	CcSEcCtD
Delavirdine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00127	0.00208	CcSEcCtD
Delavirdine—Anaemia—Cisplatin—esophageal cancer	0.00127	0.00208	CcSEcCtD
Delavirdine—Stomatitis—Capecitabine—esophageal cancer	0.00127	0.00207	CcSEcCtD
Delavirdine—Jaundice—Capecitabine—esophageal cancer	0.00127	0.00207	CcSEcCtD
Delavirdine—Conjunctivitis—Capecitabine—esophageal cancer	0.00126	0.00207	CcSEcCtD
Delavirdine—Urinary tract infection—Capecitabine—esophageal cancer	0.00126	0.00207	CcSEcCtD
Delavirdine—Malaise—Cisplatin—esophageal cancer	0.00124	0.00203	CcSEcCtD
Delavirdine—Haematuria—Capecitabine—esophageal cancer	0.00124	0.00203	CcSEcCtD
Delavirdine—Leukopenia—Cisplatin—esophageal cancer	0.00123	0.00202	CcSEcCtD
Delavirdine—Epistaxis—Capecitabine—esophageal cancer	0.00123	0.00201	CcSEcCtD
Delavirdine—Mood swings—Methotrexate—esophageal cancer	0.00119	0.00195	CcSEcCtD
Delavirdine—Bradycardia—Capecitabine—esophageal cancer	0.00119	0.00194	CcSEcCtD
Delavirdine—Myalgia—Cisplatin—esophageal cancer	0.00117	0.00192	CcSEcCtD
Delavirdine—Rhinitis—Capecitabine—esophageal cancer	0.00117	0.00191	CcSEcCtD
Delavirdine—Anxiety—Cisplatin—esophageal cancer	0.00117	0.00191	CcSEcCtD
Delavirdine—Hepatitis—Capecitabine—esophageal cancer	0.00117	0.00191	CcSEcCtD
Delavirdine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00116	0.0019	CcSEcCtD
Delavirdine—Discomfort—Cisplatin—esophageal cancer	0.00116	0.0019	CcSEcCtD
Delavirdine—Pharyngitis—Capecitabine—esophageal cancer	0.00116	0.00189	CcSEcCtD
Delavirdine—Oedema peripheral—Capecitabine—esophageal cancer	0.00115	0.00188	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00113	0.00185	CcSEcCtD
Delavirdine—Oedema—Cisplatin—esophageal cancer	0.00112	0.00184	CcSEcCtD
Delavirdine—Infection—Cisplatin—esophageal cancer	0.00112	0.00183	CcSEcCtD
Delavirdine—Erythema multiforme—Capecitabine—esophageal cancer	0.0011	0.0018	CcSEcCtD
Delavirdine—Thrombocytopenia—Cisplatin—esophageal cancer	0.0011	0.0018	CcSEcCtD
Delavirdine—Tachycardia—Cisplatin—esophageal cancer	0.0011	0.0018	CcSEcCtD
Delavirdine—Skin disorder—Cisplatin—esophageal cancer	0.00109	0.00179	CcSEcCtD
Delavirdine—Tinnitus—Capecitabine—esophageal cancer	0.00109	0.00178	CcSEcCtD
Delavirdine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00109	0.00178	CcSEcCtD
Delavirdine—Eosinophilia—Methotrexate—esophageal cancer	0.00107	0.00176	CcSEcCtD
Delavirdine—Anorexia—Cisplatin—esophageal cancer	0.00107	0.00175	CcSEcCtD
Delavirdine—Pancreatitis—Methotrexate—esophageal cancer	0.00106	0.00174	CcSEcCtD
Delavirdine—Hypotension—Cisplatin—esophageal cancer	0.00105	0.00172	CcSEcCtD
Delavirdine—Chills—Capecitabine—esophageal cancer	0.00105	0.00171	CcSEcCtD
Delavirdine—Alopecia—Capecitabine—esophageal cancer	0.00103	0.00169	CcSEcCtD
Delavirdine—Pancytopenia—Methotrexate—esophageal cancer	0.00103	0.00169	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00102	0.00168	CcSEcCtD
Delavirdine—Erythema—Capecitabine—esophageal cancer	0.00102	0.00166	CcSEcCtD
Delavirdine—Malnutrition—Capecitabine—esophageal cancer	0.00102	0.00166	CcSEcCtD
Delavirdine—Neutropenia—Methotrexate—esophageal cancer	0.00101	0.00166	CcSEcCtD
Delavirdine—Paraesthesia—Cisplatin—esophageal cancer	0.00101	0.00165	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00101	0.00165	CcSEcCtD
Delavirdine—Dyspnoea—Cisplatin—esophageal cancer	0.001	0.00164	CcSEcCtD
Delavirdine—Flatulence—Capecitabine—esophageal cancer	0.001	0.00164	CcSEcCtD
Delavirdine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000999	0.00164	CcSEcCtD
Delavirdine—Dysgeusia—Capecitabine—esophageal cancer	0.000995	0.00163	CcSEcCtD
Delavirdine—Back pain—Capecitabine—esophageal cancer	0.000982	0.00161	CcSEcCtD
Delavirdine—Decreased appetite—Cisplatin—esophageal cancer	0.000977	0.0016	CcSEcCtD
Delavirdine—Muscle spasms—Capecitabine—esophageal cancer	0.000976	0.0016	CcSEcCtD
Delavirdine—Pneumonia—Methotrexate—esophageal cancer	0.000973	0.00159	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000971	0.00159	CcSEcCtD
Delavirdine—Pain—Cisplatin—esophageal cancer	0.000962	0.00157	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000959	0.00157	CcSEcCtD
Delavirdine—Vision blurred—Capecitabine—esophageal cancer	0.000957	0.00157	CcSEcCtD
Delavirdine—Tremor—Capecitabine—esophageal cancer	0.000952	0.00156	CcSEcCtD
Delavirdine—Stomatitis—Methotrexate—esophageal cancer	0.000943	0.00154	CcSEcCtD
Delavirdine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000942	0.00154	CcSEcCtD
Delavirdine—Conjunctivitis—Methotrexate—esophageal cancer	0.00094	0.00154	CcSEcCtD
Delavirdine—Anaemia—Capecitabine—esophageal cancer	0.000939	0.00154	CcSEcCtD
Delavirdine—Feeling abnormal—Cisplatin—esophageal cancer	0.000927	0.00152	CcSEcCtD
Delavirdine—Haematuria—Methotrexate—esophageal cancer	0.000922	0.00151	CcSEcCtD
Delavirdine—Malaise—Capecitabine—esophageal cancer	0.000916	0.0015	CcSEcCtD
Delavirdine—Epistaxis—Methotrexate—esophageal cancer	0.000913	0.00149	CcSEcCtD
Delavirdine—Vertigo—Capecitabine—esophageal cancer	0.000912	0.00149	CcSEcCtD
Delavirdine—Syncope—Capecitabine—esophageal cancer	0.000911	0.00149	CcSEcCtD
Delavirdine—Leukopenia—Capecitabine—esophageal cancer	0.000909	0.00149	CcSEcCtD
Delavirdine—Palpitations—Capecitabine—esophageal cancer	0.000898	0.00147	CcSEcCtD
Delavirdine—Loss of consciousness—Capecitabine—esophageal cancer	0.000893	0.00146	CcSEcCtD
Delavirdine—Body temperature increased—Cisplatin—esophageal cancer	0.000889	0.00145	CcSEcCtD
Delavirdine—Cough—Capecitabine—esophageal cancer	0.000886	0.00145	CcSEcCtD
Delavirdine—Hypertension—Capecitabine—esophageal cancer	0.000877	0.00143	CcSEcCtD
Delavirdine—Hepatitis—Methotrexate—esophageal cancer	0.000869	0.00142	CcSEcCtD
Delavirdine—Chest pain—Capecitabine—esophageal cancer	0.000865	0.00141	CcSEcCtD
Delavirdine—Arthralgia—Capecitabine—esophageal cancer	0.000865	0.00141	CcSEcCtD
Delavirdine—Myalgia—Capecitabine—esophageal cancer	0.000865	0.00141	CcSEcCtD
Delavirdine—Pharyngitis—Methotrexate—esophageal cancer	0.000862	0.00141	CcSEcCtD
Delavirdine—Anxiety—Capecitabine—esophageal cancer	0.000862	0.00141	CcSEcCtD
Delavirdine—Discomfort—Capecitabine—esophageal cancer	0.000854	0.0014	CcSEcCtD
Delavirdine—Dry mouth—Capecitabine—esophageal cancer	0.000846	0.00138	CcSEcCtD
Delavirdine—Confusional state—Capecitabine—esophageal cancer	0.000836	0.00137	CcSEcCtD
Delavirdine—Oedema—Capecitabine—esophageal cancer	0.000829	0.00136	CcSEcCtD
Delavirdine—Hypersensitivity—Cisplatin—esophageal cancer	0.000828	0.00136	CcSEcCtD
Delavirdine—Infection—Capecitabine—esophageal cancer	0.000823	0.00135	CcSEcCtD
Delavirdine—Erythema multiforme—Methotrexate—esophageal cancer	0.000821	0.00134	CcSEcCtD
Delavirdine—Shock—Capecitabine—esophageal cancer	0.000815	0.00133	CcSEcCtD
Delavirdine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000812	0.00133	CcSEcCtD
Delavirdine—Tinnitus—Methotrexate—esophageal cancer	0.00081	0.00132	CcSEcCtD
Delavirdine—Tachycardia—Capecitabine—esophageal cancer	0.000809	0.00132	CcSEcCtD
Delavirdine—Asthenia—Cisplatin—esophageal cancer	0.000807	0.00132	CcSEcCtD
Delavirdine—Skin disorder—Capecitabine—esophageal cancer	0.000805	0.00132	CcSEcCtD
Delavirdine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000801	0.00131	CcSEcCtD
Delavirdine—Anorexia—Capecitabine—esophageal cancer	0.00079	0.00129	CcSEcCtD
Delavirdine—Chills—Methotrexate—esophageal cancer	0.000779	0.00127	CcSEcCtD
Delavirdine—Hypotension—Capecitabine—esophageal cancer	0.000775	0.00127	CcSEcCtD
Delavirdine—Diarrhoea—Cisplatin—esophageal cancer	0.000769	0.00126	CcSEcCtD
Delavirdine—Alopecia—Methotrexate—esophageal cancer	0.000767	0.00126	CcSEcCtD
Delavirdine—Malnutrition—Methotrexate—esophageal cancer	0.000756	0.00124	CcSEcCtD
Delavirdine—Erythema—Methotrexate—esophageal cancer	0.000756	0.00124	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000755	0.00124	CcSEcCtD
Delavirdine—Insomnia—Capecitabine—esophageal cancer	0.00075	0.00123	CcSEcCtD
Delavirdine—Paraesthesia—Capecitabine—esophageal cancer	0.000744	0.00122	CcSEcCtD
Delavirdine—Dysgeusia—Methotrexate—esophageal cancer	0.00074	0.00121	CcSEcCtD
Delavirdine—Dyspnoea—Capecitabine—esophageal cancer	0.000739	0.00121	CcSEcCtD
Delavirdine—Back pain—Methotrexate—esophageal cancer	0.000731	0.0012	CcSEcCtD
Delavirdine—Dyspepsia—Capecitabine—esophageal cancer	0.00073	0.00119	CcSEcCtD
Delavirdine—Decreased appetite—Capecitabine—esophageal cancer	0.000721	0.00118	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000716	0.00117	CcSEcCtD
Delavirdine—Vomiting—Cisplatin—esophageal cancer	0.000715	0.00117	CcSEcCtD
Delavirdine—Fatigue—Capecitabine—esophageal cancer	0.000715	0.00117	CcSEcCtD
Delavirdine—Vision blurred—Methotrexate—esophageal cancer	0.000713	0.00117	CcSEcCtD
Delavirdine—Rash—Cisplatin—esophageal cancer	0.000709	0.00116	CcSEcCtD
Delavirdine—Pain—Capecitabine—esophageal cancer	0.000709	0.00116	CcSEcCtD
Delavirdine—Constipation—Capecitabine—esophageal cancer	0.000709	0.00116	CcSEcCtD
Delavirdine—Dermatitis—Cisplatin—esophageal cancer	0.000708	0.00116	CcSEcCtD
Delavirdine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000701	0.00115	CcSEcCtD
Delavirdine—Anaemia—Methotrexate—esophageal cancer	0.000699	0.00114	CcSEcCtD
Delavirdine—Feeling abnormal—Capecitabine—esophageal cancer	0.000683	0.00112	CcSEcCtD
Delavirdine—Malaise—Methotrexate—esophageal cancer	0.000682	0.00112	CcSEcCtD
Delavirdine—Vertigo—Methotrexate—esophageal cancer	0.000679	0.00111	CcSEcCtD
Delavirdine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000678	0.00111	CcSEcCtD
Delavirdine—Leukopenia—Methotrexate—esophageal cancer	0.000677	0.00111	CcSEcCtD
Delavirdine—Nausea—Cisplatin—esophageal cancer	0.000668	0.00109	CcSEcCtD
Delavirdine—Cough—Methotrexate—esophageal cancer	0.00066	0.00108	CcSEcCtD
Delavirdine—Urticaria—Capecitabine—esophageal cancer	0.000658	0.00108	CcSEcCtD
Delavirdine—Abdominal pain—Capecitabine—esophageal cancer	0.000655	0.00107	CcSEcCtD
Delavirdine—Body temperature increased—Capecitabine—esophageal cancer	0.000655	0.00107	CcSEcCtD
Delavirdine—Arthralgia—Methotrexate—esophageal cancer	0.000644	0.00105	CcSEcCtD
Delavirdine—Chest pain—Methotrexate—esophageal cancer	0.000644	0.00105	CcSEcCtD
Delavirdine—Myalgia—Methotrexate—esophageal cancer	0.000644	0.00105	CcSEcCtD
Delavirdine—Discomfort—Methotrexate—esophageal cancer	0.000636	0.00104	CcSEcCtD
Delavirdine—Confusional state—Methotrexate—esophageal cancer	0.000622	0.00102	CcSEcCtD
Delavirdine—Infection—Methotrexate—esophageal cancer	0.000613	0.001	CcSEcCtD
Delavirdine—Hypersensitivity—Capecitabine—esophageal cancer	0.000611	0.000999	CcSEcCtD
Delavirdine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000604	0.000988	CcSEcCtD
Delavirdine—Skin disorder—Methotrexate—esophageal cancer	0.000599	0.000981	CcSEcCtD
Delavirdine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000597	0.000976	CcSEcCtD
Delavirdine—Asthenia—Capecitabine—esophageal cancer	0.000595	0.000973	CcSEcCtD
Delavirdine—Anorexia—Methotrexate—esophageal cancer	0.000588	0.000962	CcSEcCtD
Delavirdine—Pruritus—Capecitabine—esophageal cancer	0.000586	0.000959	CcSEcCtD
Delavirdine—Hypotension—Methotrexate—esophageal cancer	0.000577	0.000943	CcSEcCtD
Delavirdine—Diarrhoea—Capecitabine—esophageal cancer	0.000567	0.000928	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000562	0.00092	CcSEcCtD
Delavirdine—Insomnia—Methotrexate—esophageal cancer	0.000558	0.000913	CcSEcCtD
Delavirdine—Paraesthesia—Methotrexate—esophageal cancer	0.000554	0.000906	CcSEcCtD
Delavirdine—Dyspnoea—Methotrexate—esophageal cancer	0.00055	0.0009	CcSEcCtD
Delavirdine—Somnolence—Methotrexate—esophageal cancer	0.000549	0.000897	CcSEcCtD
Delavirdine—Dizziness—Capecitabine—esophageal cancer	0.000548	0.000897	CcSEcCtD
Delavirdine—Dyspepsia—Methotrexate—esophageal cancer	0.000543	0.000889	CcSEcCtD
Delavirdine—Decreased appetite—Methotrexate—esophageal cancer	0.000536	0.000878	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000533	0.000872	CcSEcCtD
Delavirdine—Fatigue—Methotrexate—esophageal cancer	0.000532	0.00087	CcSEcCtD
Delavirdine—Pain—Methotrexate—esophageal cancer	0.000528	0.000863	CcSEcCtD
Delavirdine—Vomiting—Capecitabine—esophageal cancer	0.000527	0.000862	CcSEcCtD
Delavirdine—Rash—Capecitabine—esophageal cancer	0.000523	0.000855	CcSEcCtD
Delavirdine—Dermatitis—Capecitabine—esophageal cancer	0.000522	0.000854	CcSEcCtD
Delavirdine—Headache—Capecitabine—esophageal cancer	0.000519	0.00085	CcSEcCtD
Delavirdine—Feeling abnormal—Methotrexate—esophageal cancer	0.000508	0.000832	CcSEcCtD
Delavirdine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000505	0.000826	CcSEcCtD
Delavirdine—Nausea—Capecitabine—esophageal cancer	0.000492	0.000806	CcSEcCtD
Delavirdine—Urticaria—Methotrexate—esophageal cancer	0.00049	0.000802	CcSEcCtD
Delavirdine—Abdominal pain—Methotrexate—esophageal cancer	0.000488	0.000798	CcSEcCtD
Delavirdine—Body temperature increased—Methotrexate—esophageal cancer	0.000488	0.000798	CcSEcCtD
Delavirdine—Hypersensitivity—Methotrexate—esophageal cancer	0.000455	0.000744	CcSEcCtD
Delavirdine—Asthenia—Methotrexate—esophageal cancer	0.000443	0.000724	CcSEcCtD
Delavirdine—Pruritus—Methotrexate—esophageal cancer	0.000437	0.000714	CcSEcCtD
Delavirdine—Diarrhoea—Methotrexate—esophageal cancer	0.000422	0.000691	CcSEcCtD
Delavirdine—Dizziness—Methotrexate—esophageal cancer	0.000408	0.000668	CcSEcCtD
Delavirdine—Vomiting—Methotrexate—esophageal cancer	0.000392	0.000642	CcSEcCtD
Delavirdine—Rash—Methotrexate—esophageal cancer	0.000389	0.000637	CcSEcCtD
Delavirdine—Dermatitis—Methotrexate—esophageal cancer	0.000389	0.000636	CcSEcCtD
Delavirdine—Headache—Methotrexate—esophageal cancer	0.000387	0.000632	CcSEcCtD
Delavirdine—Nausea—Methotrexate—esophageal cancer	0.000367	0.0006	CcSEcCtD
Delavirdine—CYP2C8—Metabolism—PLCE1—esophageal cancer	0.00012	0.00031	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ADH7—esophageal cancer	0.00012	0.00031	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000119	0.000306	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.000119	0.000306	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000116	0.0003	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CA1—esophageal cancer	0.000116	0.000299	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000116	0.000299	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000116	0.000298	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000116	0.000298	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CA2—esophageal cancer	0.000116	0.000297	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CA1—esophageal cancer	0.000115	0.000296	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000115	0.000296	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000113	0.000291	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.000113	0.000291	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000113	0.000291	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.000112	0.000287	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.00011	0.000284	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.000107	0.000276	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ADH7—esophageal cancer	0.000107	0.000276	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CA2—esophageal cancer	0.000106	0.000273	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000106	0.000273	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000106	0.000272	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000106	0.000272	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ADH1B—esophageal cancer	0.000106	0.000272	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CA2—esophageal cancer	0.000105	0.000271	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000105	0.000271	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000105	0.000271	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000104	0.000268	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000104	0.000268	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000104	0.000266	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000103	0.000265	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000101	0.00026	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—TYMP—esophageal cancer	0.000101	0.000259	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PLCE1—esophageal cancer	9.88e-05	0.000254	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ADH7—esophageal cancer	9.88e-05	0.000254	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CA1—esophageal cancer	9.85e-05	0.000253	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	9.85e-05	0.000253	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP26A1—esophageal cancer	9.81e-05	0.000252	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ADH7—esophageal cancer	9.8e-05	0.000252	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PLCE1—esophageal cancer	9.8e-05	0.000252	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GAPDH—esophageal cancer	9.72e-05	0.00025	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.69e-05	0.000249	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CRABP1—esophageal cancer	9.63e-05	0.000248	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ALOX15—esophageal cancer	9.56e-05	0.000246	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ADH1B—esophageal cancer	9.42e-05	0.000242	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GNG7—esophageal cancer	9.16e-05	0.000236	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTO1—esophageal cancer	9.12e-05	0.000235	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—TPI1—esophageal cancer	9.12e-05	0.000235	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CA2—esophageal cancer	9.01e-05	0.000232	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—TYMP—esophageal cancer	9.01e-05	0.000232	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP1B1—esophageal cancer	9e-05	0.000232	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—BLVRB—esophageal cancer	8.94e-05	0.00023	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	8.94e-05	0.00023	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	8.8e-05	0.000226	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	8.76e-05	0.000225	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ALDOB—esophageal cancer	8.75e-05	0.000225	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ADH1B—esophageal cancer	8.67e-05	0.000223	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ADH1B—esophageal cancer	8.59e-05	0.000221	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ALDH2—esophageal cancer	8.59e-05	0.000221	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ALOX15—esophageal cancer	8.54e-05	0.00022	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP19A1—esophageal cancer	8.46e-05	0.000218	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GAPDH—esophageal cancer	8.42e-05	0.000217	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PLCE1—esophageal cancer	8.37e-05	0.000215	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ADH7—esophageal cancer	8.37e-05	0.000215	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CRABP1—esophageal cancer	8.34e-05	0.000215	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—TYMP—esophageal cancer	8.28e-05	0.000213	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.28e-05	0.000213	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—TYMP—esophageal cancer	8.21e-05	0.000211	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTT1—esophageal cancer	8.17e-05	0.00021	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTO1—esophageal cancer	8.14e-05	0.000209	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—TPI1—esophageal cancer	8.14e-05	0.000209	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	8.07e-05	0.000208	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	8.06e-05	0.000207	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	7.99e-05	0.000205	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GNG7—esophageal cancer	7.94e-05	0.000204	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ALOX15—esophageal cancer	7.85e-05	0.000202	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ALDOB—esophageal cancer	7.81e-05	0.000201	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ALOX15—esophageal cancer	7.78e-05	0.0002	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—HMOX1—esophageal cancer	7.72e-05	0.000199	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ENO1—esophageal cancer	7.65e-05	0.000197	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTGS1—esophageal cancer	7.65e-05	0.000197	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CA1—esophageal cancer	7.6e-05	0.000195	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	7.6e-05	0.000195	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PSME2—esophageal cancer	7.54e-05	0.000194	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PSME1—esophageal cancer	7.54e-05	0.000194	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GAPDH—esophageal cancer	7.52e-05	0.000193	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTO1—esophageal cancer	7.49e-05	0.000193	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—TPI1—esophageal cancer	7.49e-05	0.000193	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CRABP1—esophageal cancer	7.45e-05	0.000192	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ALDH2—esophageal cancer	7.44e-05	0.000191	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTO1—esophageal cancer	7.43e-05	0.000191	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—TPI1—esophageal cancer	7.43e-05	0.000191	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ABCB1—esophageal cancer	7.41e-05	0.000191	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ADH1B—esophageal cancer	7.34e-05	0.000189	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ALDOB—esophageal cancer	7.18e-05	0.000185	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ALDOB—esophageal cancer	7.12e-05	0.000183	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GNG7—esophageal cancer	7.08e-05	0.000182	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTT1—esophageal cancer	7.07e-05	0.000182	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—TYMP—esophageal cancer	7.02e-05	0.00018	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	6.99e-05	0.00018	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.97e-05	0.000179	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CA2—esophageal cancer	6.95e-05	0.000179	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GAPDH—esophageal cancer	6.91e-05	0.000178	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GAPDH—esophageal cancer	6.85e-05	0.000176	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CRABP1—esophageal cancer	6.85e-05	0.000176	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	6.83e-05	0.000176	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CRABP1—esophageal cancer	6.79e-05	0.000175	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ALOX15—esophageal cancer	6.65e-05	0.000171	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ALDH2—esophageal cancer	6.64e-05	0.000171	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ENO1—esophageal cancer	6.63e-05	0.000171	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTGS1—esophageal cancer	6.63e-05	0.000171	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PSME2—esophageal cancer	6.53e-05	0.000168	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PSME1—esophageal cancer	6.53e-05	0.000168	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GNG7—esophageal cancer	6.52e-05	0.000168	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	6.51e-05	0.000167	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PLCE1—esophageal cancer	6.46e-05	0.000166	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ADH7—esophageal cancer	6.46e-05	0.000166	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GNG7—esophageal cancer	6.46e-05	0.000166	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—TPI1—esophageal cancer	6.35e-05	0.000163	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTO1—esophageal cancer	6.35e-05	0.000163	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTT1—esophageal cancer	6.31e-05	0.000162	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	6.24e-05	0.000161	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.22e-05	0.00016	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	6.12e-05	0.000157	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ALDH2—esophageal cancer	6.11e-05	0.000157	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ALDOB—esophageal cancer	6.08e-05	0.000156	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ALDH2—esophageal cancer	6.05e-05	0.000156	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ENO1—esophageal cancer	5.92e-05	0.000152	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTGS1—esophageal cancer	5.92e-05	0.000152	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GAPDH—esophageal cancer	5.86e-05	0.000151	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PSME2—esophageal cancer	5.83e-05	0.00015	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PSME1—esophageal cancer	5.83e-05	0.00015	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTT1—esophageal cancer	5.81e-05	0.000149	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CRABP1—esophageal cancer	5.8e-05	0.000149	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTT1—esophageal cancer	5.76e-05	0.000148	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	5.74e-05	0.000148	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.7e-05	0.000147	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	5.69e-05	0.000146	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.67e-05	0.000146	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ADH1B—esophageal cancer	5.67e-05	0.000146	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	5.64e-05	0.000145	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—HMOX1—esophageal cancer	5.58e-05	0.000144	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GNG7—esophageal cancer	5.52e-05	0.000142	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTGS1—esophageal cancer	5.44e-05	0.00014	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ENO1—esophageal cancer	5.44e-05	0.00014	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—TYMP—esophageal cancer	5.42e-05	0.000139	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ENO1—esophageal cancer	5.4e-05	0.000139	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTGS1—esophageal cancer	5.4e-05	0.000139	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PSME2—esophageal cancer	5.36e-05	0.000138	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PSME1—esophageal cancer	5.36e-05	0.000138	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ABCB1—esophageal cancer	5.36e-05	0.000138	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PSME2—esophageal cancer	5.32e-05	0.000137	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PSME1—esophageal cancer	5.32e-05	0.000137	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	5.3e-05	0.000136	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.27e-05	0.000135	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ALDH2—esophageal cancer	5.17e-05	0.000133	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.13e-05	0.000132	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.09e-05	0.000131	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	5.03e-05	0.000129	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CREBBP—esophageal cancer	4.95e-05	0.000127	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTT1—esophageal cancer	4.92e-05	0.000127	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—TPI1—esophageal cancer	4.9e-05	0.000126	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.9e-05	0.000126	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	4.86e-05	0.000125	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.84e-05	0.000125	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—HMOX1—esophageal cancer	4.84e-05	0.000124	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.74e-05	0.000122	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	4.73e-05	0.000122	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.7e-05	0.000121	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.64e-05	0.000119	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ABCB1—esophageal cancer	4.64e-05	0.000119	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	4.63e-05	0.000119	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ENO1—esophageal cancer	4.61e-05	0.000119	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTGS1—esophageal cancer	4.61e-05	0.000119	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	4.59e-05	0.000118	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PSME1—esophageal cancer	4.54e-05	0.000117	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PSME2—esophageal cancer	4.54e-05	0.000117	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.52e-05	0.000116	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.48e-05	0.000115	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—NOS3—esophageal cancer	4.44e-05	0.000114	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	4.35e-05	0.000112	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—HMOX1—esophageal cancer	4.32e-05	0.000111	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	4.31e-05	0.000111	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GNG7—esophageal cancer	4.26e-05	0.00011	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.23e-05	0.000109	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ABCB1—esophageal cancer	4.14e-05	0.000107	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTGS2—esophageal cancer	4.06e-05	0.000104	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.99e-05	0.000103	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—HMOX1—esophageal cancer	3.97e-05	0.000102	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.97e-05	0.000102	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—HMOX1—esophageal cancer	3.94e-05	0.000101	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	3.92e-05	0.000101	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.86e-05	9.93e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ABCB1—esophageal cancer	3.81e-05	9.8e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.8e-05	9.77e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ABCB1—esophageal cancer	3.78e-05	9.72e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.75e-05	9.65e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	3.69e-05	9.48e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CREBBP—esophageal cancer	3.58e-05	9.21e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ENO1—esophageal cancer	3.56e-05	9.15e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.56e-05	9.15e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.51e-05	9.03e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PSME2—esophageal cancer	3.51e-05	9.02e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PSME1—esophageal cancer	3.51e-05	9.02e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—EP300—esophageal cancer	3.37e-05	8.68e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.36e-05	8.65e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.3e-05	8.49e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ABCB1—esophageal cancer	3.23e-05	8.3e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NOS3—esophageal cancer	3.21e-05	8.25e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.13e-05	8.06e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.1e-05	7.98e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.03e-05	7.78e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTGS2—esophageal cancer	2.93e-05	7.54e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.86e-05	7.35e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.84e-05	7.32e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NOS3—esophageal cancer	2.78e-05	7.14e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CREBBP—esophageal cancer	2.77e-05	7.12e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.6e-05	6.68e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.55e-05	6.55e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTGS2—esophageal cancer	2.54e-05	6.53e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CREBBP—esophageal cancer	2.52e-05	6.49e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	2.5e-05	6.42e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.49e-05	6.41e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NOS3—esophageal cancer	2.48e-05	6.38e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.44e-05	6.28e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—EP300—esophageal cancer	2.44e-05	6.27e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NOS3—esophageal cancer	2.28e-05	5.87e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.27e-05	5.83e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NOS3—esophageal cancer	2.26e-05	5.81e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.16e-05	5.55e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—EP300—esophageal cancer	2.11e-05	5.43e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.09e-05	5.36e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.07e-05	5.32e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NOS3—esophageal cancer	1.93e-05	4.97e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—EP300—esophageal cancer	1.89e-05	4.85e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.8e-05	4.64e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.77e-05	4.54e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—EP300—esophageal cancer	1.73e-05	4.46e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—EP300—esophageal cancer	1.72e-05	4.42e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.67e-05	4.28e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.56e-05	4.02e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.49e-05	3.83e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—EP300—esophageal cancer	1.47e-05	3.78e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.4e-05	3.59e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.36e-05	3.51e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.28e-05	3.3e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.27e-05	3.27e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—EP300—esophageal cancer	1.13e-05	2.92e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.09e-05	2.8e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	8.39e-06	2.16e-05	CbGpPWpGaD
